X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (18) 18
female (16) 16
humans (16) 16
index medicus (16) 16
breast neoplasms - drug therapy (13) 13
middle aged (13) 13
oncology (13) 13
adult (12) 12
breast neoplasms - pathology (12) 12
chemotherapy (11) 11
aged (10) 10
cancer (10) 10
hematology, oncology and palliative medicine (10) 10
disease-free survival (9) 9
trastuzumab (9) 9
breast neoplasms - mortality (7) 7
chemotherapy, adjuvant (7) 7
therapy (7) 7
adjuvant treatment (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
cancer therapies (6) 6
care and treatment (6) 6
medical colleges (6) 6
research (6) 6
treatment outcome (6) 6
antibodies, monoclonal, humanized - administration & dosage (5) 5
clinical trials (5) 5
follow-up studies (5) 5
neoplasm staging (5) 5
product development (5) 5
randomized controlled trials as topic (5) 5
receptor, erbb-2 - metabolism (5) 5
tumors (5) 5
drug administration schedule (4) 4
drug therapy (4) 4
erbb-2 protein (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
metastasis (4) 4
oncology, experimental (4) 4
patients (4) 4
prognosis (4) 4
radiation therapy (4) 4
receptor, erbb-2 - genetics (4) 4
survival analysis (4) 4
1st-line treatment (3) 3
abridged index medicus (3) 3
analysis (3) 3
anthracyclines (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - therapy (3) 3
combined modality therapy (3) 3
docetaxel (3) 3
endocrine therapy (3) 3
kaplan-meier estimate (3) 3
mutation (3) 3
neoplasm recurrence, local - pathology (3) 3
postmenopausal women (3) 3
risk assessment (3) 3
studies (3) 3
surgery (3) 3
survival (3) 3
tamoxifen (3) 3
trastuzumab - administration & dosage (3) 3
trastuzumab - adverse effects (3) 3
aged, 80 and over (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
article (2) 2
biomarkers, tumor - analysis (2) 2
biomarkers, tumor - genetics (2) 2
breast neoplasms - chemistry (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - surgery (2) 2
carcinoma (2) 2
cell-lines (2) 2
chemotherapy, adjuvant - adverse effects (2) 2
clinical outcomes (2) 2
clinical trials, phase iii as topic (2) 2
combination (2) 2
cyclin-dependent kinase 4 (2) 2
cyclophosphamide (2) 2
diseases (2) 2
dose-response relationship, drug (2) 2
efficacy (2) 2
estrogen (2) 2
expression (2) 2
gene (2) 2
gene expression (2) 2
health aspects (2) 2
heart diseases (2) 2
heart diseases - chemically induced (2) 2
kinases (2) 2
lapatinib (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9938, pp. 164 - 172
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 811 - 821
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 6, pp. 527 - 539
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 6, pp. e240 - e248
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1021 - 1028
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9555, pp. 29 - 36
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1134 - 1142
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 3, pp. 244 - 248
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article